White House to deploy surge teams to COVID-19 hotspots; J&J reports vaccine elicits antibodies against Delta variant
The White House plans to deploy COVID-19 surge response teams to help communities experiencing or at risk for hotspots due to the Delta variant and low vaccination with vaccination, testing, contact tracing, therapeutics and staffing, White House COVID-19 Response Coordinator Jeff Zients announced yesterday.
“These are dedicated teams working with communities at higher risk for or already experiencing outbreaks due to the spread of the Delta variant and their low vaccination rate,” Zients said.
In other news, Johnson and Johnson yesterday said its single-shot COVID-19 vaccine demonstrated strong neutralizing antibody activity against the Delta variant in blood samples from eight participants in its phase 3 clinical trial of the vaccine
Related News Articles
Headline
The Centers for Disease Control and Prevention Dec. 11 released a report that found last year’s version of the COVID-19 vaccine was 76% effective in preventing…
Headline
The AHA provided recommendations to the Food and Drug Administration Dec. 1 in response to a request for information on the measurement and evaluation of…
Headline
The Food and Drug Administration has identified a Class I recall of Baxter Life2000 Ventilation Systems due to a cybersecurity issue discovered through…
Headline
Flu cases are growing or likely growing in 39 states, according to the latest Centers for Disease Control and Prevention data from Nov. 11. COVID-19…
Headline
The Food and Drug Administration yesterday published an announcement from Otsuka ICU Medical saying that the company issued a voluntary recall for a mislabeled…
Headline
A study published Oct. 30 by the American Heart Association found that people have an elevated risk of heart attack and stroke following flu and COVID-19…